Old Web
English
Sign In
Acemap
>
Paper
>
10-year survival with imatinib: final evaluation of randomized CML-study
10-year survival with imatinib: final evaluation of randomized CML-study
2017
R. Hehlmann
Michael Lauseker
Susanne Saussele
Markus Pfirrmann
S. Krause
Hans Jochem Kolb
Andreas Neubauer
D. K. Hossfeld
Christoph Nerl
Alois Gratwohl
G. M. Bärlocher
Dominik Heim
K. Kohlbrenner
A. Voskanyan
Leopold Balleisen
M. C. Göbeler
M. Hänel
Jolanta Dengler
C. Falge
Lothar Kanz
Stephan Kremers
A. Burchert
M. Kneba
Frank Stegelmann
C. A. Köhne
Hans Walter Lindemann
Cornelius F. Waller
Michael Pfreundschuh
Karsten Spiekermann
W.E. Berdel
Andreas Hochhaus
J. Hasford
Keywords:
General surgery
Imatinib
Medicine
Physical therapy
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]